Wolverine Trading, LLC Adverum Biotechnologies, Inc. Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	SELL	$0.68 - $1.59 $9,165 - $21,431	-13,479 Reduced 50.41%	13,258 $21,000
Q1 2023 May 15, 2023	BUY	$0.62 - $0.85 $8,357 - $11,458	13,480 Added 101.68%	26,737 $19,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $10.3 $2,252 - $42,961	-4,171 Reduced 23.93%	13,257 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $16,730 - $168,703	17,428 New	17,428 $17,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.